Parkinson’s Disease and PEMFs eBook
$9.99
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder in people over the age of sixty. Aging is a major factor for increased risk of developing PD. With the aging of population worldwide, the frequency of PD is expected to increase dramatically in the coming decades. Nearly one million people in the US are living with Parkinson’s Disease.
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder in people over the age of sixty. Aging is a major factor for increased risk of developing PD. With the aging of population worldwide, the frequency of PD is expected to increase dramatically in the coming decades. Nearly one million people in the US are living with Parkinson’s Disease. It is estimated that 6-10 million people worldwide have PD, affecting all races and ethnicities. The incidence of PD rises rapidly with age, affecting approximately 1% of the population older than sixty years and approximately 4% of those older than either years. Parkinson’s Disease (PD) is a chronic and progressive movement disorder primarily, meaning that symptoms continue and worsen over time. The cause is unknown, and there is no cure. Conventional treatment options include medication and surgery to manage symptoms. Neither reduces progression.